Mobia Medical, Inc. Common Stock (MOBI) Stock
Key stats
- Market cap
- $448.43M
- Price / Earnings ratio
- -8.7x
- EPS (TTM)
- -$54.78
- Volume
- Loading
- 52-week high
- $15.29
- 52-week low
- $8.03
Source: third-party data provider, as of November 13, 2026
Compare with MOBI
Recent news

Mobia Medical Q2 Earnings Call Highlights
Mobia Medical Q2 Earnings Call Highlights
MOBI

Mobia Medical poised for commercial expansion, BofA says in initial coverage
Mobia Medical poised for commercial expansion, BofA says in initial coverage
MOBI
Technical indicators
- RSI 14
- 72.27
- MACD 12/26/9
- 0.73
- EMA 9 of MACD
- 0.44
- MACD histogram
- 0.28
- SMA 50
- $10.08
- Price above SMA 50
- EMA 50
- $10.54
- Price above EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Mobia Medical Q2 Earnings Call Highlights
Mobia Medical Q2 Earnings Call Highlights
MOBI

Mobia Medical poised for commercial expansion, BofA says in initial coverage
Mobia Medical poised for commercial expansion, BofA says in initial coverage
MOBI
About Mobia Medical, Inc. Common Stock
Mobia Medical is a commercial-stage medical device company focused on stroke recovery solutions for patients with long-term motor impairments. Its Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the first FDA-approved, clinically validated therapy designed for chronic ischemic stroke survivors experiencing moderate to severe upper extremity impairment. Stroke remains one of the leading causes of long-term disability in the United States.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard John Foust | CEO, President & Director | 1974 |
| Mr. Nelson Bunker Curnes | Chief Financial Officer | 1983 |
| Mr. Prashant B. Rawat | Chief Operating Officer | 1974 |
| Mr. Thomas Jordan Curnes II, M.B.A. | Co-Founder | 1979 |
| Mr. Douglas T. Ellison | Chief Commercial Officer | 1963 |
| Dr. Navzer Engineer M.D., Ph.D. | Co-Founder & Chief Scientific Officer | — |
| Mr. Chase C. Leavitt J.D. | General Counsel & Corporate Secretary | 1982 |
| Mr. Philip B. Freed | Vice President of Marketing | — |
| Ms. Steffanie Cook | Vice President of Human Resources | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 72.27
- MACD 12/26/9
- 0.73
- EMA 9 of MACD
- 0.44
- MACD histogram
- 0.28
- SMA 50
- $10.08
- Price above SMA 50
- EMA 50
- $10.54
- Price above EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $19.00
- Average
- $19.00
- High
- $19.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +11.5 | -0.7 | -15.0 | -1.7 | -17.5 | +17.2 | +33.8 |



